chr2-216414831-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014140.4(SMARCAL1):​c.127G>A​(p.Ala43Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,614,194 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 47 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 32 hom. )

Consequence

SMARCAL1
NM_014140.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.407
Variant links:
Genes affected
SMARCAL1 (HGNC:11102): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein shows sequence similarity to the E. coli RNA polymerase-binding protein HepA. Mutations in this gene are a cause of Schimke immunoosseous dysplasia (SIOD), an autosomal recessive disorder with the diagnostic features of spondyloepiphyseal dysplasia, renal dysfunction, and T-cell immunodeficiency. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022759438).
BP6
Variant 2-216414831-G-A is Benign according to our data. Variant chr2-216414831-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 260337.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-216414831-G-A is described in Lovd as [Likely_benign]. Variant chr2-216414831-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0133 (2029/152300) while in subpopulation AFR AF= 0.0465 (1934/41554). AF 95% confidence interval is 0.0448. There are 47 homozygotes in gnomad4. There are 969 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 47 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SMARCAL1NM_014140.4 linkuse as main transcriptc.127G>A p.Ala43Thr missense_variant 3/18 ENST00000357276.9 NP_054859.2
SMARCAL1NM_001127207.2 linkuse as main transcriptc.127G>A p.Ala43Thr missense_variant 3/18 NP_001120679.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SMARCAL1ENST00000357276.9 linkuse as main transcriptc.127G>A p.Ala43Thr missense_variant 3/182 NM_014140.4 ENSP00000349823 P1

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2030
AN:
152182
Hom.:
47
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0467
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00907
GnomAD3 exomes
AF:
0.00335
AC:
842
AN:
251470
Hom.:
24
AF XY:
0.00235
AC XY:
319
AN XY:
135902
show subpopulations
Gnomad AFR exome
AF:
0.0448
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00134
AC:
1957
AN:
1461894
Hom.:
32
Cov.:
32
AF XY:
0.00112
AC XY:
813
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.0458
Gnomad4 AMR exome
AF:
0.00250
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000112
Gnomad4 OTH exome
AF:
0.00273
GnomAD4 genome
AF:
0.0133
AC:
2029
AN:
152300
Hom.:
47
Cov.:
33
AF XY:
0.0130
AC XY:
969
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.0465
Gnomad4 AMR
AF:
0.00373
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00898
Alfa
AF:
0.00279
Hom.:
13
Bravo
AF:
0.0152
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0474
AC:
209
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.00402
AC:
488
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Schimke immuno-osseous dysplasia Benign:4
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJun 28, 2023- -
not provided Benign:3
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxJan 13, 2024See Variant Classification Assertion Criteria. -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
3.8
DANN
Benign
0.93
DEOGEN2
Benign
0.013
T;T;.;T;.
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.55
T;.;T;T;T
MetaRNN
Benign
0.0023
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
.;L;.;L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.70
N;N;N;N;N
REVEL
Benign
0.010
Sift
Benign
0.19
T;T;T;T;T
Sift4G
Pathogenic
0.0
D;T;D;T;D
Polyphen
0.0020
.;B;.;B;.
Vest4
0.052, 0.053
MVP
0.24
MPC
0.22
ClinPred
0.0026
T
GERP RS
0.32
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.028
gMVP
0.14

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2066524; hg19: chr2-217279554; API